Tcg Crossover Management, LLC Rapt Therapeutics, Inc. Transaction History
Tcg Crossover Management, LLC
- $415 Million
- Q1 2025
A detailed history of Tcg Crossover Management, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 13,090,200 shares of RAPT stock, worth $128 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
13,090,200
Previous 13,135,260
0.34%
Holding current value
$128 Million
Previous $20.8 Million
23.05%
% of portfolio
3.85%
Previous 3.39%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
74Shares Held
109MCall Options Held
41.3KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA13.1MShares$129 Million0.5% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$123 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$115 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$90.6 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.28MShares$81.2 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $291M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...